PubRank

Jose G Guillem

Author PubWeight™ 83.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 2002 2.71
2 Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003 2.69
3 Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004 2.52
4 Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009 2.50
5 Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003 2.16
6 Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol 2005 1.92
7 The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg 2006 1.90
8 Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003 1.73
9 Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002 1.66
10 Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002 1.65
11 Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum 2010 1.64
12 Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol 2004 1.62
13 Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity. Virchows Arch 2006 1.62
14 Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002 1.59
15 Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 2003 1.59
16 Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 2014 1.59
17 Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 2004 1.58
18 Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003 1.54
19 Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 2008 1.54
20 Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Ann Surg Oncol 2004 1.54
21 Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002 1.50
22 T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 2005 1.49
23 Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005 1.49
24 Long-term results of local excision for rectal cancer. Ann Surg 2002 1.44
25 Feasibility of ex vivo FDG PET of the colon. Radiology 2009 1.43
26 Long-term outcome of perianal Paget's disease. Dis Colon Rectum 2003 1.35
27 Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 2005 1.26
28 A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006 1.26
29 Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol 2007 1.24
30 Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum 2007 1.20
31 Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Hum Pathol 2008 1.14
32 Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 2006 1.07
33 Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol 2002 1.06
34 Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 2003 1.05
35 Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon Rectum 2002 1.02
36 Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004 1.02
37 Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw 2014 1.01
38 Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 2011 1.01
39 Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 2011 1.01
40 Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004 1.00
41 Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiother Oncol 2013 1.00
42 Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2005 0.99
43 Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 2009 0.99
44 Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Ann Surg Oncol 2011 0.98
45 A predictive model for lymph node yield in colon cancer resection specimens. Ann Surg 2011 0.98
46 Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Hum Pathol 2007 0.93
47 Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002 0.93
48 Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg 2005 0.93
49 Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg 2002 0.93
50 Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum 2003 0.91
51 Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol 2006 0.89
52 Abdominoperineal resection for rectal cancer: historic perspective and current issues. Surg Oncol Clin N Am 2005 0.89
53 Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case. Dis Colon Rectum 2005 0.89
54 Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2005 0.87
55 Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol 2007 0.84
56 Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol 2013 0.81
57 Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer. Ann Surg Oncol 2003 0.81
58 A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 2003 0.81
59 Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer? Dis Colon Rectum 2015 0.80
60 Accuracy of endorectal ultrasound for measurement of the closest predicted radial mesorectal margin for rectal cancer. Dis Colon Rectum 2012 0.80
61 Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clin Colorectal Cancer 2006 0.79
62 Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Dis Colon Rectum 2009 0.79
63 The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg 2005 0.77
64 Ileal diverticulitis: clinical and radiographic presentation. Dig Dis Sci 2004 0.77
65 Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome. Ann Surg 2012 0.77
66 Surgical treatment of rectal cancer: radical resection. Surg Oncol Clin N Am 2006 0.77
67 Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. Fam Cancer 2014 0.76
68 Surgical issues in rectal cancer: a 2004 update. Clin Colorectal Cancer 2004 0.76
69 Improving the vision of colonoscopy: does the fine print really matter? Cancer Prev Res (Phila) 2008 0.75
70 Nonoperative strategies for rectal cancer following a complete clinical response to preoperative chemoradiation: a few considerations. Oncology (Williston Park) 2014 0.75
71 Multidisciplinary management of resectable rectal cancer. New developments and controversies. Oncology (Williston Park) 2008 0.75
72 The genetic counselor: an important surgical ally in the optimal care of the cancer patient. Adv Surg 2012 0.75
73 Erratum to: Comparing outcomes of robotic versus open mesorectal excision for rectal cancer. BJS Open 2022 0.75
74 Multimodality management of locally advanced rectal cancer. Am Surg 2003 0.75